TOULOUSE, France, LAKELAND Mich.--(BUSINESS WIRE)--Regulatory News: Following numerous calls received since the press release of February 15, 2024, ABIONYX Pharma (FR0012616852 - ABNX - eligible for ...
QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results